Search Results
Dr. Coleman on Findings from the AZURE Trial for Breast Cancer Treatment
San Antonio Breast Cancer Symposium 2008: Zoledronic acid may have anti-tumour properties
2010 SABCS Interview with Robert E. Coleman, M.D.
Copy of Dr. Coleman on Classifying Patients With Ovarian Cancer
Dr. Coleman on Classifying Patients With Ovarian Cancer
Bone Drug Fails to Stop Breast Cancer
The Azure Trial: What's Next?
Dr. Burstein on the Results of the APT Trial for HER2+ Breast Cancer
Next steps for drug re-purposing
Dr. Yardley on the Results of the APT and APHINITY Trials for HER2+ Breast Cancer
Metastatic microenvironment of breast cancer: Clinical implications: Robert E. Coleman, UK
Robert Coleman - Bone Protection and Improved Survival
